Argenx Se (ARGX) Current Taxes (2017 - 2025)
Argenx Se (ARGX) posted Current Taxes of $42.2 million for Q4 2025, down 99.77% on a QoQ basis from $18.2 billion in Q2 2025, and up 215.23% year-over-year from $13.4 million in Q4 2024.
Argenx Se (ARGX) Current Taxes (2017 - 2025) Analysis & Trends
Argenx Se's Current Taxes history runs 9 years deep, the most recent figure standing at $42.2 million for Q4 2025.
- Quarterly Current Taxes rose 215.23% year-over-year to $42.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.2 million (up 215.23% YoY) and the FY2025 annual result came in at $42.2 million, up 215.23% from the prior year.
- Current Taxes was $42.2 million for Q4 2025 at Argenx Se, down from $18.2 billion in the prior quarter.
- Across five years, Current Taxes topped out at $18.2 billion in Q2 2025 and bottomed at $1.2 million in Q2 2021.
- A 5-year average of $1.8 billion and a median of $4.5 million in 2023 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2022 — Current Taxes fell 26.28% — and 2025, when it surged 130107.21%.
- Argenx Se's Current Taxes stood at $4.3 million in 2021, then decreased by 26.28% to $3.2 million in 2022, then surged by 36.25% to $4.3 million in 2023, then surged by 208.95% to $13.4 million in 2024, then jumped by 215.23% to $42.2 million in 2025.
- Business Quant data shows ARGX's Current Taxes at $42.2 million in Q4 2025, $18.2 billion in Q2 2025, and $13.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 63.52 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42.21 Mn |
| Jun 30, 2025 | 18.16 Bn |
| Dec 31, 2024 | 13.39 Mn |
| Jun 30, 2024 | 13.95 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Jun 30, 2023 | 4.61 Mn |
| Dec 31, 2022 | 3.18 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Dec 31, 2021 | 4.32 Mn |
| Jun 30, 2021 | 1.15 Mn |
| Dec 31, 2020 | 3.40 Mn |
| Jun 30, 2020 | 474,729.32 |
| Dec 31, 2019 | 380,769.36 |
| Jun 30, 2019 | 424,735.58 |
| Dec 31, 2018 | 939,369.26 |
| Jun 30, 2018 | 674,296.09 |
| Dec 31, 2017 | 702,927.22 |
| Jun 30, 2017 | 656,430.94 |